Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 3, 2025 • 9:31 PM ET
As of June 3, 2025 • 9:31 PM ET
Date/Time | Source | News Release |
---|---|---|
07/04/2024 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, July 4th, 2024 |
07/04/2024 05:43 AM EDT | US Earnings Reports | Expected earnings - Antibe Therapeutics |
02/14/2024 08:06 AM EST | SeekingAlpha | Antibe Therapeutics Non-GAAP EPS of -C$0.08 |
02/13/2024 06:00 AM EST | US Earnings Reports | Expected US Company Earnings on Tuesday, February 13th, 2024 |
02/13/2024 04:32 AM EST | US Earnings Reports | Expected earnings - Antibe Therapeutics |
11/13/2023 11:01 AM EST | SeekingAlpha | Antibe Therapeutics reports Q2 results |
11/13/2023 06:00 AM EST | US Earnings Reports | Expected US Company Earnings on Monday, November 13th, 2023 |
11/13/2023 04:31 AM EST | US Earnings Reports | Expected earnings - Antibe Therapeutics |
08/14/2023 02:10 PM EDT | SeekingAlpha | Antibe Therapeutics GAAP EPS of -C$0.11 |
06/29/2023 04:08 PM EDT | SeekingAlpha | Antibe Therapeutics GAAP EPS of -$0.37 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.